Article

Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients

Department of Nuclear Medicine (CDI), Hospital Clínic, University of Barcelona, Barcelona, Spain.
European journal of nuclear medicine and molecular imaging (Impact Factor: 5.22). 12/2005; 32(11):1283-7. DOI: 10.1007/s00259-005-1867-z
Source: PubMed

ABSTRACT Despite the widespread use of sentinel lymph node (SLN) biopsy in breast cancer patients, some controversy exists about the correct management of extra-axillary nodes, especially those located in the internal mammary chain. The aim of this study was to evaluate the incidence of SLNs in this region, calculate the lymphoscintigraphic and surgical detection rates and evaluate the clinical impact on staging and therapeutic decisions.
The study involved 383 consecutive women diagnosed with early breast cancer with T1 or T2 tumours. Eight patients had a bilateral tumour, which brought the total to 391 lesions. Lymphoscintigraphy was performed on the day before surgery by injection of (99m)Tc-labelled nanocolloid. The injection site was subdermal (68 patients), peritumoural (107 patients) or intratumoural (216 patients). During surgery a gamma probe was used to guide the surgeon and the SLNs were removed. SLNs were analysed by a conventional pathological study and processed for H&E examination and immunohistochemistry.
Lymphoscintigraphy detected at least one SLN in 369 out of the 391 procedures (94.4%). SLNs were found in the axillary chain in 367 cases and in the internal mammary chain in 55. In two of these 55 cases (3.6%), the SLN was the only one detected. There was no drainage to the internal mammary chain in any case of subdermal injection but such drainage was found in 15.9% of cases with peritumoural injection and 17.6% of those with intratumoural injection. Compared with tumours located in the outer quadrants, a higher percentage of tumours located in the inner quadrants showed drainage to the internal mammary chain (p<0.001). A total of 42 SLNs in the internal mammary chain could be removed in 32 patients without appreciable morbidity. In 20 cases both axillary and internal mammary SLNs were negative, in four both were positive, and in five axillary SLNs were positive and internal mammary SLNs were negative. More interestingly, in the remaining patient with both axillary and internal mammary SLNs, the axillary SLN was negative while malignant cells were found in the internal mammary region. In the evaluation of the clinical impact of internal mammary SLN biopsy, we found that staging was modified from pN1a to pN1c in four patients and, more importantly, from pN0 to pN0(i+) in one patient. The change in stage led to a modification of the postoperative treatment plan with respect to radiotherapy and systemic therapy.
Evaluation of the SLNs in the internal mammary chain provides more accurate staging of breast cancer patients. If internal mammary sampling is not performed, patients can be understaged. This technique can offer a better indication of those patients who will benefit from selective treatment options like radiotherapy to this region or systemic therapy.

0 Followers
 · 
270 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: The objective of this prospective study was to determine the feasibility, safety and performance of a new method for sentinel lymph node (SLN) detection in endometrial cancer (EC) using transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR). METHODS: From 2006 to 2011, 74 patients with high-risk EC were included in the study. Twenty-four hours before surgery 148MBq of 99mTc-nanocolloid (8mL) were injected into two spots in the anterior and posterior myometrium using an ultrasound-guided transvaginal puncture. SLN were localized preoperatively by lymphoscintigraphy and intraoperatively with gamma probe. After SLN biopsy the patients underwent a complete laparoscopic pelvic and paraaortic lymphadenectomy. RESULTS: The TUMIR method was successfully achieved in 67/74 patients (90.5%). SLN were identified in 55 women (74.3%). No adverse effects were observed. Pelvic drainage was observed in 87.2% of women and paraaortic SLN were identified in 45.4%, with 12.8% of the patients draining only in this area. The mean number of SLN retrieved was 2.8 per patient (range 1 to 9). Metastatic disease was found in 13 (23.6%) patients. Metastatic involvement of the paraaortic lymph nodes was observed in 4 (30.7%) cases. All were identified by TUMIR. The sensitivity and negative predictive value of SLN detected by TUMIR to detect metastasis were 92.3% (95% CI 22.9-100) and 97.7% (95% CI 82.0-100), respectively. CONCLUSIONS: TUMIR is a safe, feasible method to detect SLN in patients with EC, having a good detection rate and providing representative information of the lymphatic drainage of EC.
    Gynecologic Oncology 10/2012; 128(1). DOI:10.1016/j.ygyno.2012.10.008 · 3.69 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Axillary node status is a major prognostic factor in early-stage disease. Traditional staging needs levels I and II axillary lymph node dissection. Axillary involvement is found in 10%-30% of patients with T1 (<2 cm) tumours. Sentinel lymph node biopsy is a minimal invasive method of checking the potential nodal involvement. It is based on the assumption of an orderly progression of lymph node invasion by metastatic cells from tumour site. Thus, when sentinel node is free of metastases the remaining nodes are free, too (with a false negative rate lesser than 5%). Moreover, Randomized trials demonstrated a marked reduction of complications associated with the sentinel lymph node biopsy when compared with axillary lymph node dissection. Currently, the sentinel node biopsy procedure is recognized as the standard treatment for stages I and II. In these stages, this approach has a positive node rate similar to those observed after lymphadenectomy, a significant decrease in morbidity and similar nodal relapse rates at 5 years. In this review, the indications and contraindications of the sentinel node biopsy are summarized and the methodological aspects discussed. Finally, the new technologic and histologic developments allow to develop a more accurate and refinate technique that can achieve virtually the identification of 100% of sentinel nodes and reduce the false negative rate.
    Journal of Oncology 08/2012; 2012:361341. DOI:10.1155/2012/361341
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: RESUMEN El estado de los ganglios axilares constituye el factor pronóstico más importante en el cáncer de mama (CM), de modo que la afectación de los mismos disminuye la supervivencia a los 5 años hasta en un 40%. Este hecho condiciona la importancia de la linfadenectomía axilar en la estadificación del tumor y, como consecuencia, en la elección de la terapia adyuvante. Pero esta técnica quirúrgica, sin embargo, no está por completo exenta de morbilidad, produciéndose linfedema en miembro superior en un 3-12%. Aproximadamente un 30% de las pacientes con CM sin afectación ganglionar, presentan recaída de la enfermedad a los 10 años de seguimiento. Diversos estudios retrospectivos, realizados en pacientes con ganglios negativos y con técnicas especiales de anatomía patológica (AP), mostraron metástasis ocultas en algunas de ellas. El análisis AP habitual de todos los ganglios extirpados en la linfadenectomía, consiste en la bisección de cada uno y estudio mediante tinción con hematoxilina-eosina (HE). El coste adicional que supondría analizar de forma asistencial todas las adenopatías mediante cortes seriados por niveles y tinción con HE y técnicas de inmunohistoquímica (IHQ) sería muy elevado. Pero con la realización de la biopsia selectiva del ganglio centinela (GC) se consigue la extirpación de entre 1-3 ganglios como primeras estaciones de drenaje linfático del tumor y, por tanto, representativos del estado de la axila. El estudio de estos ganglios con técnicas especiales de AP, no supone coste económico excesivamente elevado y permite la estadificación correcta. Mientras que en el melanoma maligno está perfectamente establecida la técnica y sus indicaciones, en el CM todavía existe controversia en algunos puntos En este trabajo se analizan los resultados de la técnica del GC en 256 pacientes diagnosticadas de CM. Todas las pacientes con tumores infiltrantes fueron sometidas a lifadenectomia completa después de localizar el GC, por tanto se trata de una de las más extensas fases de validación, lo que nos ha permitido analizar estadísticamente todos los aspectos de la técnica llegando a las siguientes conclusiones: - La eficacia de la técnica isotópica para la localización del GC ha sido del 90,5%. Los parámetros que han influido de forma independiente en la captación isotópica son: la edad de la paciente y el resultado histopatológico del GC. Las pacientes mayores de 50 años y con metástasis axilares con rotura capsular tienen menor probabilidad de visualización linfogammagráfica del GC. - El uso combinado del colorante ha mejorado la eficacia de la técnica desde el 90,5% hasta el 94,4%. Los factores con influencia significativa en la tinción del colorante han sido: la ubicación del tumor en la mama y la técnica diagnóstica. - Los factores más significativos en cuanto a la detección de drenaje a cadena MI han sido la vía de inyección del radiofármaco y la edad de la paciente. - El estudio histopatológico del GC predice el estado del resto de ganglios axilares en todas las pacientes con CM con una precisión del 97,5%. La tasa de falsos negativos en esta serie ha sido del 5,4%. - El estudio AP del GC mediante secciones seriadas separadas por niveles y tinción con HE y con técnicas de IHQ, mejora la sensibilidad de la técnica y disminuye la tasa de falsos negativos. - La probabilidad de metástasis del GC aumenta significativamente a medida que se incrementa el tamaño del tumor y el polimorfismo nuclear. - La probabilidad de metástasis en los ganglios no centinela aumenta a medida que se incrementa la invasión metastásica del GC, sobre todo cuando hay rotura capsular, y en pacientes con mitosis grado 2 y 3. __________________________________________________________________________________________________ The sentinel lymph node (SLN), first drainage site of a primary lesion, can be identified via radioactive tracers and dyes. Lymph-node samples can be obtained by selective biopsy of SLN, which on closer inspection are believed to be representative of the state of the axilla. This biopsy is not excessively expensive and allows proper assessment of the patient's state. In this work the results of the SLN technique have been studied in the validation stage of 256 patients diagnosed with breast cancer. After SLN were located, all the patients with tumour infiltration were subjected to full lymph node dissection. The univariant and multivariate statistical analyses of the technique and their results have enabled the following conclusions to be drawn: In patients over 50 years of age with axillary metastasis with capsular break through, visualization of the SLN lymphogammagraphy is less likely. Combining the technique with the use of dye improved efficiency levels from 90.5% to 94.4%. Staining with dye is more successful in tumours located in the upper external area and diagnosed via punction with a large-gauge needle. Internal mammary chain drainage is more common in younger patients and with an intraparenchimatous injection of the tracer. The histopathological study of SLN predicts the state of the other axillary lymph nodes at 97.5% accuracy. The rate of false negatives was 5.4%. Other factors influencing increased rates of false negative results were: the surgeons level of experience, patients over 50, use of only one tracer to locate the SLN and the diagnosis of the tumour via any surgical technique. The histopathological study of SLN via a series of sections, separated by levels and staining with hematoxiline-eosina and with immuno-histochemical techniques, improves the sensitivity of the technique and decreases the rate of false negatives. The likelihood of SLN metastasis increases significantly in line with increased tumour size and nuclear degree. The probability of metastasis in non-sentinel lymph nodes increases in line with metastatic spreading to SLN, above all when there is capsular breakage, and in patients with mitosis stage 2-3.